12 Va. Admin. Code § 5-20-80 - Elements of committee review process
Statutory Authority: §§ 32.1-12 and 32.1-12.1 of the Code of Virginia.
The following state regulations pages link to this page.
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
12VAC5-20-80. Elements of committee review process.
A. No human research shall be conducted or authorized by a person, institution, or agency unless a research review committee has reviewed and approved the proposed human research project giving consideration to:
1. The adequacy of the description of the potential benefits and risks involved and the adequacy of the methodology of the human research;
2. The degree of the risk and, if the human research is nontherapeutic, whether it presents greater than minimal risk;
3. Whether the rights and welfare of the human subjects involved are adequately protected;
4. Whether the risks to the human subjects are outweighed by the potential benefits to them;
5. Whether the risks to subjects are minimized (i) by using procedures that are consistent with sound human research design and that do not unnecessarily expose subjects to risk and (ii) whenever appropriate, by using currently accepted procedures for diagnostic or treatment purposes;
6. Whether additional safeguards have been included in the study to protect the rights and welfare of the subjects when some or all of the subjects are likely to be incapable of providing informed consent or are otherwise vulnerable to coercion or undue inducement, such as children, prisoners, pregnant women, mentally disabled persons, or economically or educationally disadvantaged persons;
7. Whether the informed consent is to be obtained by methods that are adequate and appropriate and whether the written consent form is adequate and appropriate in both content and language for the particular human research and for the particular subjects of the human research;
8. Whether the persons proposing to supervise or conduct the particular human research are appropriately competent and qualified;
9. Whether criteria for selection of subjects are equitable; and
10. Whether the human research conforms with other requirements of the department, where applicable.
B. The committee shall consider a research proposal within 45 days after its submission to the committee. In order for the research proposal to be approved, it shall receive the approval of a majority of the committee members present at a meeting for which a quorum exists. A committee shall notify investigators and the institution in writing of its decision to approve or disapprove the research proposal or of modifications required to secure committee approval.
C. During the committee review of research proposals, no personal identifiers of present or potential subjects shall be stated.
D. The committee shall develop a written description of the procedure to be followed when a subject has a complaint about a research project in which he is participating or has participated.
E. Any subject who has a complaint about a research project in which he is participating or has participated shall be referred to the committee to determine if there has been a violation of the protocol.
F. The committee shall have the authority to suspend or terminate approval of research that is not being conducted in accordance with the committee requirements or that has been associated with unexpected serious harm to the subjects. Any suspension or termination of approval shall include a statement of the reasons for the committee's action and shall be reported promptly to the investigator, appropriate institutional officials, the department or agency head, and the commissioner.
G. The chair of the committee shall provide a written report to the head of the institution of any violation of the human research protocol that led the committee to suspend or terminate the human research.
H. The committee shall require reports from approved research projects at least annually to ensure conformity with the approved proposal. The frequency of such reports shall be consistent with the nature and degree of risk of each research project. The committee shall also require a report at the conclusion of the research project.
I. The committee shall ensure compliance with the Health Insurance Portability and Accountability Act of 1996 (42 USC § 1320d et seq.), if applicable, and federal and state regulations regarding the use and disclosure of PHI created for human research. In particular, authorization shall be obtained for the use and disclosure of PHI created for the purpose of human research, except as otherwise permitted by 45 CFR 164.512(i).
J. When cooperating institutions conduct some or all of the human research involving some or all of the subjects of the human research, each cooperating institution shall be responsible for safeguarding the rights and welfare of the subjects and for complying with this chapter, provided however, in complying with this chapter, institutions may enter into joint review, rely upon the review of another qualified committee, or come to similar agreements aimed at avoiding duplication of effort. Any such agreement shall be in writing and designate a lead institution, which shall be the institution responsible for reporting and handling any possible misconduct in the human research. Such agreements shall be entered into by the committee chair with the approval of a majority of the committee members. If an institution or agency does not have a research review committee, such agreements shall be approved and entered into by the chief executive officer of the institution or his designee.
§§ 32.1-12 and 32.1-12.1 of the Code of Virginia.
Derived from VR355-01-400 § 8, eff. July 1, 1993; amended, Volume 26, Issue 13, eff. March 31, 2010; Volume 32, Issue 08, eff. January 14, 2016.